AC Immune SA (ACIU)
4.65
+0.68
(+17.13%)
USD |
NASDAQ |
May 31, 16:00
4.79
+0.14
(+3.01%)
After-Hours: 20:00
AC Immune Revenue (Annual): 16.48M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.48M |
| December 31, 2022 | 4.126M |
| December 31, 2021 | |
| December 31, 2020 | 16.46M |
| December 31, 2019 | 111.18M |
| Date | Value |
|---|---|
| December 31, 2018 | 7.066M |
| December 31, 2017 | 20.56M |
| December 31, 2016 | 23.57M |
| December 31, 2015 | 40.62M |
| December 31, 2014 | 33.12M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
4.126M
Minimum
2022
111.18M
Maximum
2019
37.06M
Average
16.47M
Median
Revenue (Annual) Benchmarks
| CRISPR Therapeutics AG | 370.00M |
| Addex Therapeutics Ltd | 1.796M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 7.838M |
| MoonLake Immunotherapeutics | -- |